Genpharmasec Stock Hits New 52-Week Low at Rs. 1.57

Genpharmasec, a microcap company in the Trading & Distributors industry, has reached a significant milestone by hitting a new 52-week low of Rs. 1.57 on November 4, 2025. This decline marks a notable drop from its 52-week high of Rs. 4.32, reflecting a challenging year for the stock, which has seen a performance decrease of 49.04% over the past year.
Despite today's performance, where Genpharmasec outperformed its sector by 0.81%, the stock continues to trade below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. The broader market context shows the Sensex experiencing a negative shift, closing down by 521.73 points to 83,478.91, which may have contributed to the stock's current position.

Financial metrics reveal that Genpharmasec has faced challenges in profitability, with a weak EBIT to Interest ratio of -0.14 and a low return on equity of 1.84%. While the company reported a significant growth in operating profit of 2500% in June, the overall long-term performance remains below par, as evidenced by its underperformance against the BSE500 index over various time frames.